膜性肾病动物模型研究进展

2KrauseDSFulzeleKCaticAetal．DifferentialregulationofmyeloidleukemiasbythebonemarrowmicroenvironmentJ．NatMed201319111513-1517．3EsteyE．Acutemyeloidleukemia2013updateonriskstratificationandmanagementJ．AmJHematol2013884318．4LerchEEspeliVZuccaEetal．PrognosisofacutemyeloidleukemiainthegeneralpopulationdatafromsouthernSwitzerlanJ．Tumori2009953303-310．5KayserSDhnerKKrauterJetal．Theimpactoftherapy-relat-edacutemyeloidleukemiaonoutcomein2853adultpatientswithnewlydiagnosedAMLJ．Blood201111772137-2145．6MetzelerKMaharryKＲadmacherMetal．TET2mutationsim-provethenewEuropeanLeukemiaNetriskclassificationofacutemyloidleukemiaaCancerandLeukemiaGroupBstudyJ．JClinOncol201129101373-1381．7GaidzikVBullingerLSchlenkＲetal．ＲUNX1mutationsina-cutemyeloidleukemiaresultsfromacomprehensivegeneticandclinicalanalysisfromtheamlstudygroupJ．JClinOncol201129101364-1372．8VanVlierberghePPatelJAbdel-WahabOetal．PHF6muta-tionsinadultacutemyeloidleukemiaJ．Leukemia2011251130-134．9PatelJGonenMFigueroaMetal．Prognosticrelevanceofinte-gratedgeneticprofilinginacutemyeloidleukemiaJ．NEnglJMed2012366121079-1089．10FaderlSWetzlerMＲizzieriDetal．ClofarabinepluscytarabinecomparedwithcytarabinealoneinolderpatientswithrelapsedorrefractoryacutemyelogenousleukemiaresultsfromtheCLASSICItrialJ．JClinOncol201230202492-2499．11FeldmanEJLancetJEKolitzJEetal．First-in-manstudyofCPX-351aliposomalcarriercontainingcytarabineanddaunorubi-cininafixed51molarratioforthetreatmentofrelapsedandre-fractoryacutemyeloidleukemiaJ．JClinOncol2011298979-985．12CastaigneSPautasCTerreCetal．Effectofgemtuzumabozo-gamicinonsurvivalofadultpatientswithde-novoacutemyeloidleukaemiaALFA-0701arandomizedopen-labelphase3studyJ．Lancet201237998251508-1516．13SmithCWangQChinCSetal．ValidationofITDmutationsinFLT3asatherapeutictargetinhumanacutemyeloidleukaemiaJ．Nature20124857397260-263．14ＲavandiFCortesJEJonesDetal．PhaseI/IIstudyofcombi-nationtherapywithsorafenibidarubicinandcytarabineinyoun-gerpatientswithacutemyeloidleukemiaJ．JClinOncol201028111856-1862．15MacdonaldDAAssoulineSEBrandweinJetal．AphaseⅠ/Ⅱstudyofsorafenibincombinationwithlowdosecytarabineinelder-lypatientswithacutemyeloidleukemiaorhigh-riskmyelodysplas-ticsyndromefromtheNationalCancerInstituteofCanadaClinicalTrialsGrouptrialIND186J．LeukLymphoma2013544760-766．16UyGＲettiqMMotabiIetal．Aphase1/2studyofchemosen-sitizationwiththeCXCＲ4antagonistplerixaforinrelapsedorre-fractoryacutemyeloidleukemiaJ．Blood2012119173917-3924．2015-01-08646000MNMN。MN。MNHeymannC-BSAMNHBVMN、MN、MN。doi10．3969/j．issn．1002-266X．2015．34．043Ｒ332A1002-266X201534-0096-031203422012-S-37。MN。MNc5b-91。。20%、2。MN6920155534MN。MNMN。MN。1MN1．1HeymannHNHNMNSD、Wistar、MunichWistar、LewisPVGHN。AHNPHN。200～300g2～9mL/kg20～240mg/kgIgG。AHNPHNAHNMNPHN。3HNMNAHNMNAHNPHN。4SDFX1A0．5、1mL/100g1/6MNⅡ、MNⅠMN。Ⅰ～ⅣMN。PHNMNMNHNmegalinMNMN。1．2C-BSAC-BSABSA。C-BSA、、、5。MNICＲBALB/cMN3mg/kg6。C-BSAMNC-BSAIgG1IgG4MN7。83、10、16mg/kgC-BSA3mg/kg10mg/kgMNⅠ16mg/kgMNⅡ～Ⅲ。C-BSA。。MNⅠ～ⅢMNMN。1．3MNHEK293NC1α3α3NC1DBA/1DBA/1、MN9。3NC1cBSA3NC1GBM3NC13NC1GBMMN。MN。DBA/1C57BL/63NCL10。1．4ACEMNACE11。。ACEMN。2MN2．1HBVMNHBVMN。HBsAg、HBeAg、HBcAgHBV。HBeAgHBVMN12。HBsAg、HBeAg7920155534SD“”HBVMN。2．2MNSLE。Ⅰ～Ⅵ6ⅤMNMN。SLEGBM13。MNF1。14DBA/24F1C57BL6×DBA/2MN。、MN。2．3DNMNDN。DNMN。15DNDNC-BSADNMN。3MNMNMN。MN4MNMN。MNMN。1．J．2011312108-112．2．M．2008387-401．3．AHNPHNJ．199393211-214．4．HeymannJ．200828285-87．5WuCCChenJSLinYF．Experimentalmodelofmembranousne-phropathyinmicesequenceofhistologicalandbiochemicaleventsJ．LabAnim2008423350-359．6ChenJSChenAChangLCetal．Mousemodelofmembranousnephropathyinducedbycationicbovineserumalbuminantigendose-responserelationsandstraindifferencesJ．NephrolDialTransplant200419112721-2728．7DebiecHLefeuFKemperMJetal．Early-childhoodmembra-nousnephropathyduetocationicbovineserumalbuminJ．NEnglJMed2011364222101-2110．8．J．200812377322-7325．9ZhangJJMalekpourMLuoWetal．Murinemembranousne-phropathyimmunizationwithα3IVcollagenfragmentinducessubepithelialimmunecomplexesandFcγＲ-independentnephroticsyndromeJ．JImmunol201218873268-3277．10HopferHMaronＲButzmannUetal．Theimportanceofcell-mediatedimmunityinthecourseandseverityofautoimmuneanti-glomerularbasementmembranediseaseinmiceJ．FASEBJ2003178860-868．11MaruyamaSCantuE3rdDemartinoCetal．Membranousglo-merulonephritisinducedinthepigbyantibodytoangiotensin-con-vertingenzymeconsiderationsonitsrelevancetothepathogenesisofhumanidiopathicmembranousglomerulonephritisJ．JAmSocNephrol199910102102-2108．12LinCY．HepatitisBvirus-associatedmembraneousnephropathyclinicalfeaturesimmunologicalprofilesandoutcomeJ．Neph-ron199055137-44．13JacobLViardJPAllenetBetal．Amonoclonalanti-double-strandedDNAautoantibodybindstoa94-kDacell-surfaceproteinonvariouscelltypesvianucleosomesoraDNA-histonecomplexJ．ProcNatlAcadSciUSA198986124669-4673．14．———J．200084207-212．15．J．201232245495-5496．2015-05-228920155534